The present invention relates to pharmaceutical compounds of the Formula (I) or a pharmaceutically acceptable salt or composition thereof and methods of their use for the treatment of pain respiratory conditions as well as inhibiting the Transient Receptor Potential Al ion channel (TRPA1).